Article
T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to…
medRxiv · 2024 · Cho, N. W.; Guldberg, S. M.; Nabet, B. Y.; Yu, J. Z.; Kim, E. J.; Hiam-Galvez, K. J.; Yee, J. L.; DeBarge, R.; Tenvooren, I.; Ashitey, N. A.; Lynce, F.; Dillon, D. A.; Rosenbluth, J. M.; Spitzer, M. H.
Key facts
| Title | T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL-1 and TNFa Inflammation. |
|---|---|
| First author | Cho, N. W.; Guldberg, S. M.; Nabet, B. Y.; Yu, J. Z.; Kim, E. J.; Hiam-Galvez, K. J.; Yee, J. L.; DeBarge, R.; Tenvooren, I.; Ashitey, N. A.; Lynce, F.; Dillon, D. A.; Rosenbluth, J. M.; Spitzer, M. H. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2022.09.20.508732 |
| Devices mentioned | K073490 |
| Product codes mentioned | CFN, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1